3394F Quantitative her2 ihc evaluation brst cx
Other
Also known as: HER2 testing, HER2 IHC, quantitative HER2
Quantitative human epidermal growth factor receptor 2 immunohistochemistry evaluation of breast cancer tissue; pathologic assessment and quantification of HER2/neu protein expression by immunohistochemistry.
Clinical Context
Quality measure for testing of HER2 status in breast cancer. HER2 positive tumors are associated with more aggressive behavior and benefit from targeted therapy (trastuzumab).
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.